(New Title) establishing safety and care requirements for clinician-administered drugs.

Sponsors & Cosponsors

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

1. Interim Study Report: Not Recommended for Future Legislation 10/15/2026 (Vote 11-0; )

   10/19/2026House

2. Executive Session: 10/14/2026 10:00 am GP 229

   10/1/2026House

3. Subcommittee Work Session: 10/07/2026 10:00 am GP 229

   9/17/2026House

4. Subcommittee Work Session: 09/09/2026 10:00 am GP 229

   8/21/2026House

5. Refer for Interim Study: MA VV 05/14/2026 HJ 13 P. 2

   5/14/2026House

6. Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 6

   5/1/2026House

7. Executive Session: 04/29/2026 10:00 am GP 229

   4/22/2026House

8. Subcommittee Work Session: 04/22/2026 10:00 am GP 229

   4/16/2026House

9. Public Hearing: 04/07/2026 02:15 pm GP 159

   4/2/2026House

10. Subcommittee Work Session: 04/08/2026 10:00 am GP 229

    4/1/2026House

11. Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): MA VV (in recess of) 02/19/2026 HJ 5 P. 127

    3/2/2026House

12. Introduced (in recess of) 02/19/2026 and referred to Health, Human Services and Elderly Affairs HJ 5 P. 124

    2/26/2026House

13. Ought to Pass with Amendment #2025-3029s, MA, VV; OT3rdg; 01/07/2026; SJ 1

    1/7/2026Senate

14. Committee Amendment # 2025-3029s, AA, VV; 01/07/2026; SJ 1

    1/7/2026Senate

15. Committee Report: Ought to Pass with Amendment # 2025-3029s, 01/07/2026; Vote 5-0; CC; SC 46

    10/22/2025Senate

16. Rereferred to Committee, MA, VV; 03/06/2025; SJ 6

    3/6/2025Senate

17. Committee Report: Rereferred to Committee, 03/06/2025; Vote 5-0; CC; SC 11

    2/21/2025Senate

18. Hearing: 02/12/2025, Room 101, LOB, 09:15 am; SC 9

    2/5/2025Senate

19. Introduced 01/09/2025 and Referred to Health and Human Services; SJ 3

    1/23/2025Senate

Bill Text

• Introduced

  1/23/2025

  PDF